Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Med Cannabis Cannabinoids. 2018 Dec 4;1(2):104–111. doi: 10.1159/000495582

Table 2.

In vitro antimicrobial activities of compound 4 and 10 (IC50 in μg/mL)

Compound Antifungal
C. neoformans
Antibacterial
E. coli
4 13.67 na
10 na 0.8
Ciprofloxacin na 0.01
Amphotericin B 1.29 na

IC50, the concentration that causes 50% inhibition of growth; na, not active.